From: Secondary prevention after ischaemic stroke: the ASPIRE-S study
 | Proportion reaching target (%) | |||
---|---|---|---|---|
All patients | On lipid-lowering medication | No lipid-lowering treatment | p-value | |
Lipid targetsa (mmol/l) | ||||
 TC < 5.0 | (200) 86.2 | (196) 89.5 | (4) 30.8 | p < 0.001 |
 TC < 4.5 | (174) 75.0 | (171) 78.1 | (3) 23.1 | p < 0.001 |
 LDL < 2.5 | (170) 76.9 | (167) 79.5 | (3) 27.3 | p < 0.001 |
 LDL < 1.8 | (97) 43.9 | (96) 45.7 | (1) 9.1 | p < 0.05 |
 | All patients | On anti-hypertensive medication | No anti-hypertensive medication | p-value |
BP targets (mmHg) | ||||
 BP <140/90 | (91) 36.6 | (62) 33.2 | (29) 46.8 | P = 0.05 |
 BP <135/85 | (69) 27.7 | (46) 24.6 | (23) 37.1 | P = 0.06 |
 BP <130/80 | (40) 16.1 | (24) 12.8 | (16) 25.8 | p < 0.05 |